Heather May, BCCCP, PharmD, FCCM: No relevant financial relationship(s) to disclose.
Describe limitations of VTE management, antiplatelet and anticoagulation considerations in critically ill oncology patients including theoretical hold considerations, preferred agents, and risk benefit evaluation
